A Multi-center Clinical Study of Zanubrutinib in Combination With First-line Chemoimmunotherapy in Patients With Grade 3A High-risk Follicular Lymphoma
Clinical trial NCT06742879 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06742879
- Sponsor
- Zhengzhou University
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-12-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.